Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Obstructive Lung Diseases

Free Subscription 29.07.2019 1 Allergy 4 Am J Respir Crit Care Med 1 BMJ 1 Clin Exp Allergy 4 J Allergy Clin Immunol 4 J Asthma 1 Lancet Respir Med 1 Pediatr Pulmonol 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Respir Med 1 Respir Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Allergy

1. CHOI Y, Kim YM, Lee HR, Mun J, et al
   Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma.
   Allergy. 2019 Jul 22. doi: 10.1111/all.13997.
   PubMed     Text format     Abstract available
   
   

   
   Am J Respir Crit Care Med

2. LIPWORTH B, Kuo CR
   Resistance Heterogeneity and Small Airways Asthma Phenotype.
   Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201905-1060.
   PubMed     Text format    
   
   
3. BEASLEY R, Harper J, Bird G, Maijers I, et al
   Reply to: Inhaled Corticosteroids and Adult Asthma.
   Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201907-1408.
   PubMed     Text format    
   
   
4. BOULET LP, Nair P
   Inhaled Corticosteroids and Adult Asthma.
   Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201907-1301.
   PubMed     Text format    
   
   
5. SIDDIQUI S
   Reply to: Resistance Heterogeneity and Small Airways Asthma Phenotype.
   Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201906-1274.
   PubMed     Text format    
   
   

   
   BMJ

6. MAHASE E
   Asthma: assess all patients for future attack risk and tailor care accordingly, new guideline advises.
   BMJ. 2019;366:l4846.
   PubMed     Text format    
   
   

   
   Clin Exp Allergy

7. MILANZI EB, Koppelman GH, Smit HA, Wijga AH, et al
   Role of timing of exposure to pets and dampness or mold on asthma and sensitization in adolescence.
   Clin Exp Allergy. 2019 Jul 23. doi: 10.1111/cea.13471.
   PubMed     Text format     Abstract available
   
   

   
   J Allergy Clin Immunol

8. GUNAWARDANA NC, Zhao Q, Carayannopoulos LN, Tsai K, et al
   The effects of house dust mite sublingual immunotherapy (SLIT)-tablet effects on immunological biomarkers and nasal allergen challenge symptoms.
   J Allergy Clin Immunol. 2017 Sep 11. pii: S0091-6749(17)31429.
   PubMed     Text format     Abstract available
   
   
9. BARNES PJ, Szefler SJ, Reddel HK, Chipps BE, et al
   Symptoms and perception of airway obstruction in asthma: clinical implications for use of reliever medications.
   J Allergy Clin Immunol. 2019 Jul 19. pii: S0091-6749(19)30941.
   PubMed     Text format     Abstract available
   
   
10. CAMORETTI-MERCADO B, Lockey RF
    The beta adrenergic theory of bronchial asthma: 50 years later.
    J Allergy Clin Immunol. 2019 Jul 22. pii: S0091-6749(19)30946.
    PubMed     Text format    
    
    
11. DEBEUF N, Zhakupova A, Steiner R, Van Gassen S, et al
    The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice.
    J Allergy Clin Immunol. 2019 Jul 19. pii: S0091-6749(19)30943.
    PubMed     Text format     Abstract available
    
    

    
    J Asthma

12. ODLING M, Jonsson M, Janson C, Melen E, et al
    Lost in the transition from pediatric to adult healthcare? Experiences of young adults with severe asthma.
    J Asthma. 2019 Jul 22:1-9. doi: 10.1080/02770903.2019.1640726.
    PubMed     Text format     Abstract available
    
    
13. PATE CA, Qin X, Bailey CM, Zahran HS, et al
    Cost barriers to asthma care by health insurance type among children with asthma.
    J Asthma. 2019 Jul 25:1-7. doi: 10.1080/02770903.2019.1640730.
    PubMed     Text format     Abstract available
    
    
14. MOSNAIM G, Belice PJ, Galant S, Kim Y, et al
    The Impact of Caregiver Health Literacy on Healthcare Outcomes for Low Income Minority Children with Asthma.
    J Asthma. 2019 Jul 25:1-12. doi: 10.1080/02770903.2019.1648507.
    PubMed     Text format     Abstract available
    
    
15. MARTIN A, Bauer V, Datta A, Masi C, et al
    Development and Validation of an Asthma Exacerbation Prediction Model using Electronic Health Record (EHR) Data.
    J Asthma. 2019 Jul 25:1-13. doi: 10.1080/02770903.2019.1648505.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Respir Med

16. SHAHEEN S
    Elucidating the causes of asthma: how can we do better?
    Lancet Respir Med. 2019;7:e25.
    PubMed     Text format    
    
    

    
    Pediatr Pulmonol

17. OMAND JA, Maguire JL, O'Connor DL, Parkin PC, et al
    Agreement between a health claims algorithm and parent-reported asthma in young children.
    Pediatr Pulmonol. 2019 Jul 22. doi: 10.1002/ppul.24432.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

18. GONZALEZ J, Henschke CI, Yankelevitz DF, Seijo LM, et al
    Emphysema phenotypes and lung cancer risk.
    PLoS One. 2019;14:e0219187.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. GARCIA E, Urman R, Berhane K, McConnell R, et al
    Effects of policy-driven hypothetical air pollutant interventions on childhood asthma incidence in southern California.
    Proc Natl Acad Sci U S A. 2019 Jul 22. pii: 1815678116.
    PubMed     Text format     Abstract available
    
    

    
    Respir Med

20. HISINGER-MOLKANEN H, Pallasaho P, Haahtela T, Lindqvist A, et al
    The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.
    Respir Med. 2019;155:121-126.
    PubMed     Text format     Abstract available
    
    

    
    Respir Res

21. YANG J, Ramirez Moral I, van 't Veer C, de Vos AF, et al
    Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Respir Res. 2019;20:165.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: